• SCOPE Europe 2025 Best of Show Entries

    Oct 10 | Clinical Research News | It’s time to vote for the SCOPE Europe 2025 Best of Show awards! This year, there are 22 finalists that will be displaying their products in Barcelona. Attendees of SCOPE Europe are invited and encouraged to identify extraordinary innovative technologies used by life science professionals and to vote on the most impactful new products of the year. More

  • Out-of-the-Box CRA First ‘Agentic Teammate’ to Join Study Teams

    Oct 08 | Clinical Research News | Clinical research associates (CRAs) may soon be working alongside an artificial intelligence (AI) agent offering relief from some of the drudgery of the job, including crunching data from a dozen or more data sources in search of meaningful insights and actionable information. Medable has just launched Agent Studio, the first agentic AI platform purpose-built for life sciences that comes with an out-of-the-box CRA agent. More

  • Unlocking New Pathways for Treating Recurrent Ovarian Cancer

    Oct 07 | Clinical Research News | Recurrent ovarian cancer treatment has always had dismal responses because differences between cancer patients are not fully understood. To tackle this challenge, a team from the Department of Oncology of the Lausanne University Hospital and the Lausanne, Switzerland branch of the Ludwig Institute for Cancer Research conducted a large-scale clinical research study to provide insight into how immune and genomic signatures may finally guide more effective care. More

  • Clinical Trials Drive Innovation in Infant Gut Health

    Oct 02 | Clinical Research News | In a food system that prioritizes profits and quantity over nutritional quality, most babies born today lack the gut microbes they need before kindergarten to train their immune system. Persephone Biome, a California-based biotech company, is tackling this issue with its latest product, the Daily Synergistic Synbiotic. More

  • Combining eCOA and Objective Digital Endpoints: Promise and Pitfalls

    Sep 30 | Clinical Research News | The clinical research industry is awash in new data streams. With the rise of wearables, sensors, and smartphone-based assessments, objective digital measures are increasingly complementing traditional patient-reported outcomes. But should these endpoints be combined, or is it better to keep them separate? A recent SCOPE 365 ClinEco Connect session brought together experts and industry participants to wrestle with this question. More

  • nPhase Mixes Data, Evidence in One Platform, N-Power Medicine, VieCure Enter Partnership, More

    Sep 25 | Clinical Research News | nPhase launches the first industry platform to harmonize real-world evidence and clinical trial data in one system; N-Power Medicine and VieCure have entered a strategic partnership; and more. More

  • Follow the Money: Adjustment Disorder Clinical Trial, Solving Trial Recruitment Failure, More

    Sep 24 | Clinical Research News | Reunion Neuroscience will continue with its ongoing REKINDLE Phase 2 clinical trial in Adjustment Disorder (AjD) in cancer; Trially has launched Margo, an agentic AI solution that multiplies trial enrollment by converting patient matches into participants; and more. More

  • Paldara, Mayo Clinic Push Phage Therapy Toward First Human Trials

    Sep 23 | Clinical Research News | Phage therapy, a treatment that uses viruses to fight bacterial infections, may finally be heading toward mainstream clinical practice. Paldara, a biotech startup, is developing a delivery platform that promises to stabilize and sustain bacteriophages and make phage therapy accessible for patients. More

  • Building Momentum: Strengthening Patient Retention in Clinical Trials

    Sep 19 | Clinical Research News | In clinical research, keeping patients engaged throughout the course of a trial is not only a logistical goal but a scientific necessity. Retention ensures that datasets remain complete, representative, and reliable. High dropout rates, by contrast, mean gaps in data, higher costs to backfill participants, and extended timelines that frustrate everyone involved. More

  • Psilocybin Shows Potential as Candidate for Delayed Aging

    Sep 16 | Clinical Research News | Psilocybin—the psychoactive compound found in “magic mushrooms”—has often been viewed in a negative light due to the reputation of psychedelics, even among experts. But new research suggests that the compound could have a role in slowing the aging process. More
View more articles
 
DXX-Industry-spotlight
SOT

The Scope of Things podcast explores clinical research and its possibilities, promise, and pitfalls. Clinical Research News Senior writer Deborah Borfitz welcomes guests who are visionaries closest to the topics, but who can still see past their piece of the puzzle. Focusing on game-changing trends and out-of-the-box operational approaches in the clinical research field, the Scope of Things podcast is your no-nonsense, insider’s look at clinical research today.

Read More